Aura Biosciences Inc (AURA)
US Market

Aura Biosciences Inc (AURA) Financial Statements


Aura Biosciences Inc Financial Overview

Aura Biosciences Inc's market cap is currently ―. The company's EPS TTM is $-2.008; its P/E ratio is -4.47; Aura Biosciences Inc is scheduled to report earnings on November 22, 2023, and the estimated EPS forecast is $-0.52. See an overview of income statement, balance sheet, and cash flow financials.
Jun 23Mar 23Dec 22Sep 22Jun 22
Income Statement-
Total Revenue---$ 0.00$ 0.00
Gross Profit-----
EBIT$ -18.30M$ -17.47M$ 25.64M$ -16.05M$ -13.82M
EBITDA$ -18.00M$ -17.14M$ 25.97M$ -15.75M$ -13.52M
Net Income Common Stockholders$ -18.30M$ -17.47M$ 25.64M$ -15.90M$ -13.47M
Balance Sheet-
Cash, Cash Equivalents and Short-Term Investments$ 162.03M$ 173.54M$ 188.83M$ 111.52M$ 122.13M
Total Assets$ 192.74M$ 206.02M$ 223.94M$ 143.15M$ 135.02M
Total Debt$ 20.41M$ 20.64M$ 20.86M$ 21.07M$ 684.00K
Net Debt$ -141.62M$ -152.90M$ -167.97M$ -90.45M$ -121.45M
Total Liabilities$ 26.30M$ 25.76M$ 28.35M$ 28.09M$ 5.93M
Stockholders Equity$ 166.44M$ 180.26M$ 195.58M$ 115.05M$ 129.09M
Cash Flow-
Free Cash Flow$ -14.84M$ -16.52M$ -18.37M$ -10.82M$ -10.70M
Operating Cash Flow$ -14.64M$ -16.41M$ -18.01M$ -10.76M$ -10.63M
Investing Cash Flow$ 21.41M$ -66.88M$ -16.88M$ 17.95M$ -43.44M
Financing Cash Flow$ 2.48M$ 201.00K$ 95.20M$ 104.00K$ 309.00K
Currency in USD

Aura Biosciences Inc Earnings and Revenue History

Aura Biosciences Inc Debt to Assets

Aura Biosciences Inc Cash Flow

Aura Biosciences Inc Forecast EPS vs Actual EPS

What's Included in PREMIUM?
Make informed decisions based on Top Analysts' activity
Know what industry insiders are buying
Get actionable alerts from top Wall Street Analysts
Find out before anyone else which stock is going to shoot up
Get powerful stock screeners & detailed portfolio analysis